LA
AXNX

Lee Ainslie’s Axonics, Inc. Common Stock AXNX Stock Holding History

Lee Ainslie’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-7,953
Closed -$401K – 518
2023
Q2 		$401K Sell
7,953
-9,574
-55% -$509K 0.01% 288
2023
Q1 		$956K Buy
17,527
+6,506
+59% +$380K 0.02% 154
2022
Q4 		$689K Buy
+11,021
New +$731K 0.02% 173

Other funds holding AXNX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Lee Ainslie's AXNX Position: Q3 2023 in Review

Lee Ainslie sold out of Axonics, Inc. Common Stock (AXNX) in Q3 2023, closing a stake of 7,953 shares — an estimated $401K sold.

Lee Ainslie first reported a position in AXNX in Q4 2022 and held it in 3 quarters. The position peaked at $956K in Q1 2023. 221 funds tracked by Wall St. Rank hold AXNX as of Q3 2023.

  • Lee Ainslie reported no remaining Axonics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Lee Ainslie sold 7,953 Axonics, Inc. Common Stock shares in Q3 2023, an estimated $401K.
  • Lee Ainslie first reported a position in Axonics, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
  • Lee Ainslie's Axonics, Inc. Common Stock position peaked at $956K in Q1 2023.
  • 221 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q3 2023.

Based on Maverick Capital's 13F filing for Q3 2023, filed 14 Nov 2023.